[HTML][HTML] Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and …
B Fourneaux, V Chaire, C Lucchesi, M Karanian… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract The PI3K/AKT/mTOR pathway plays a crucial role in the development of
leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235) …
leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235) …
[PDF][PDF] Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical …
B Fourneaux, V Chaire, C Lucchesi, M Karanian… - academia.edu
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas
but leads to ERK activation through mTORC2 Page 1 Oncotarget 7878 www.impactjournals.com/oncotarget …
but leads to ERK activation through mTORC2 Page 1 Oncotarget 7878 www.impactjournals.com/oncotarget …
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical …
B Fourneaux, V Chaire, C Lucchesi… - …, 2017 - pubmed.ncbi.nlm.nih.gov
The PI3K/AKT/mTOR pathway plays a crucial role in the development of leiomyosarcomas
(LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235), PI3K (BKM120) …
(LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235), PI3K (BKM120) …
[HTML][HTML] Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and …
B Fourneaux, V Chaire, C Lucchesi, M Karanian… - Oncotarget, 2016 - oncotarget.com
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas
but leads to ERK activation through mTORC2: biological and clinical... | Oncotarget Online …
but leads to ERK activation through mTORC2: biological and clinical... | Oncotarget Online …
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical …
B Fourneaux, V Chaire, C Lucchesi, M Karanian… - Oncotarget, 2017 - europepmc.org
Abstract The PI3K/AKT/mTOR pathway plays a crucial role in the development of
leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235) …
leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235) …
[PDF][PDF] Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical …
B Fourneaux, V Chaire, C Lucchesi, M Karanian… - pdfs.semanticscholar.org
ABSTRACT The PI3K/AKT/mTOR pathway plays a crucial role in the development of
leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235) …
leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235) …
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical …
B Fourneaux, V Chaire, C Lucchesi, M Karanian… - Oncotarget, 2016 - oncotarget.com
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but
leads to ERK activation through mTORC2: biological and clinical... | Oncotarget Online ISSN …
leads to ERK activation through mTORC2: biological and clinical... | Oncotarget Online ISSN …
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical …
B Fourneaux, V Chaire, C Lucchesi, M Karanian… - Oncotarget, 2017 - europepmc.org
Abstract The PI3K/AKT/mTOR pathway plays a crucial role in the development of
leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235) …
leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235) …